Skip to main content
VIVOZON PHARMACEUTICAL CO., LTD. logo

VIVOZON PHARMACEUTICAL CO., LTD. — Investor Relations & Filings

Ticker · 082800 ISIN · KR7082800004 KO Manufacturing
Open in API
Filings indexed 590 across all filing types
Latest filing 2022-06-29 Capital/Financing Update
Country KR South Korea
Listing KO 082800

About VIVOZON PHARMACEUTICAL CO., LTD.

https://www.vivozon.com/

VIVOZON PHARMACEUTICAL CO., LTD. is a research and development company specializing in the discovery and commercialization of innovative drugs, with a primary focus on pain and central nervous system (CNS) diseases. The company utilizes a multi-target drug development platform to create new chemical entities that act on multiple targets to achieve synergistic efficacy. This approach integrates efficacy-based screening from the early stages of discovery to identify candidate substances with a high potential for successful clinical development. Its lead pipeline candidate is Opiranserin (VVZ-149), a first-in-class, non-narcotic injectable analgesic for post-operative pain management. The company is actively expanding its pipeline to address a broader range of unmet medical needs within the CNS field.

Recent filings

Filing Released Lang Actions
전환사채(해외전환사채포함)발행후만기전사채취득(제18회차 CB)
Capital/Financing Update Classification · 100% confidence The document is a formal regulatory disclosure regarding the 'acquisition of convertible bonds before maturity' (Put option exercise). It details the specific bond series (18th series), the amount acquired, the reason (early redemption request), and the method of acquisition. This falls under capital structure and financing updates related to debt instruments.
2022-06-29 Korean
분기보고서 (2022.03)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for Vivozon Healthcare, covering the period from January 1, 2022, to March 31, 2022. It contains detailed financial statements, management discussion, and corporate information, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2022
2022-05-16 Korean
[기재정정]분기보고서 (2022.03)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for Vivozon Healthcare, which includes detailed financial statements, notes to financial statements, and management discussions for the period of January 1, 2022, to March 31, 2022. It is a formal regulatory filing containing substantive financial data, not an announcement or a certification. Therefore, it is classified as an Interim/Quarterly Report. Q1 2022
2022-05-16 Korean
대표이사변경
Board/Management Information Classification · 100% confidence The document is a formal announcement regarding the change of the CEO (Representative Director) of Vivozon Healthcare. It details the previous and new CEOs, the reason for the change, the date of the board resolution, and the professional background of the new appointee. This aligns perfectly with the definition for Board/Management Information (MANG).
2022-05-06 Korean
기타시장안내(최대주주의의무보유관련)
Major Shareholding Notification Classification · 100% confidence The document is a short regulatory announcement from the Korea Exchange regarding the mandatory share holding period (lock-up) for the major shareholder of Vivozone Healthcare. It is not a financial report, but rather a notice of regulatory compliance regarding share ownership and lock-up obligations. Since it does not fit into specific categories like 'Director's Dealing' or 'Share Issue', and is a regulatory notification, it falls under the RNS (Regulatory Filings) category.
2022-04-20 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act (Article 147). It details changes in share ownership, including the number of shares held, the purpose of holding (management influence), and specific transaction details (acquisitions, transfers, and changes in the representative reporter). This corresponds to the 'Major Shareholding Notification' category.
2022-04-13 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.